Aishah M Alsibaee (Aishah Alsibaee)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Extracellular Matrix

Molecularly Imprinted

Top Venues

Molecules (Basel, Switzerland)

Microbiology spectrum

This page only lists publications with an associated author ORCID identifier.

Publications

Aishah M Alsibaee, Haya I Aljohar, Mohamed W Attwa, Ali Saber Abdelhameed, Adnan A Kadi
Investigation of Fenebrutinib Metabolism and Bioactivation Using MS 3 Methodology in Ion Trap LC/MS. Molecules (Basel, Switzerland) 28 (10) (2023)
Aishah M Alsibaee, Hanan M Al-Yousef, Huda S Al-Salem
Quinazolinones, the Winning Horse in Drug Discovery. Molecules (Basel, Switzerland) 28 (3) (2023)
Aishah M Alsibaee, Hanan M Al-Yousef, Huda S Al-Salem
Quinazolinones, the Winning Horse in Drug Discovery. Molecules (Basel, Switzerland) 28 (3) (2023)
Aishah M Alsibaee, Hanan M Al-Yousef, Huda S Al-Salem
Quinazolinones, the Winning Horse in Drug Discovery. Molecules (Basel, Switzerland) 28 (3) (2023)
Filippo Prencipe, Aishah M Alsibaee, Zainab Khaddem, Padraig Norton, Aisling M Towell, Afnan F M Ali, Gerard Reid, Orla M Fleury, Timothy J Foster, Joan A Geoghegan, Isabel Rozas, Marian P Brennan
Allantodapsone is a Pan-Inhibitor of Staphylococcus aureus Adhesion to Fibrinogen, Loricrin, and Cytokeratin 10. Microbiology spectrum 10 (3) (2022)